{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T19:13:41Z","timestamp":1778786021912,"version":"3.51.4"},"reference-count":68,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunopharmacology and Immunotoxicology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.3109\/08923971003646597","type":"journal-article","created":{"date-parts":[[2010,3,3]],"date-time":"2010-03-03T05:46:08Z","timestamp":1267595168000},"page":"533-542","source":"Crossref","is-referenced-by-count":4,"title":["Monoclonal antibodies used as prophylactic, therapeutic and diagnostic agents"],"prefix":"10.1080","volume":"32","author":[{"given":"Marita","family":"Chakhtoura","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander M.","family":"Abdelnoor","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2010,3,3]]},"reference":[{"key":"e_1_3_1_2_1","first-page":"531","article-title":"Monoclonal antibodies in nuclear medicine","volume":"26","author":"Keenan A.M.","year":"1985","unstructured":"Keenan, A.M., Harbert, J.C., Larson, S.M. Monoclonal antibodies in nuclear medicine. J. Nucl. Med. 1985, 26, 531\u2013537.","journal-title":"J. Nucl. Med"},{"key":"e_1_3_1_3_1","volume-title":"11th Hour Introduction to Microbiology","author":"McCall D.","year":"2001","unstructured":"McCall, D., Stock, D., Achey, P. Antigen-antibody reactions in host defense and in serology. In 11th Hour Introduction to Microbiology (pp. 204\u2013205). Massachusetts: Blackwell Science Inc., 2001."},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000223443.80696.5b"},{"key":"e_1_3_1_5_1","volume-title":"Advances in Clinical Chemistry","author":"Spiegel H.E","year":"1989","unstructured":"Spiegel, H.E. Advances in Clinical Chemistry. Vol. 27. Academic Press, Inc., Utah, USA. 1989."},{"key":"e_1_3_1_6_1","volume-title":"Biotechnology and Safety Assessment","author":"Thomas J.A.","year":"1993","unstructured":"Thomas, J.A., Thomas, M.J. New biologics: their development, safety, and efficacy. In Thomas, J.A., Myers, L.A., eds. Biotechnology and Safety Assessment (pp. 15\u201320). New York: Raven Press, 1993."},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2005.09.005"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199609053351008"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0889-799"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702477"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200003023420902"},{"key":"e_1_3_1_12_1","unstructured":"Monoclonal antibodies. Making treatment decisions. http:\/\/www.cancer.org\/docroot\/ETO\/content\/ETO_1_4X_Monoclonal_Antibody_Therapy_Passive_Immunotherapy.asp. Updated October 27 2009. (accessed November 18 2009)."},{"key":"e_1_3_1_13_1","unstructured":"Bishop M.R. Monoclonal antibodies. http:\/\/www.meds.com\/immunotherapy\/monoclonal_antibodies.html (accessed November 20 2009.)."},{"key":"e_1_3_1_14_1","first-page":"1490","article-title":"Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia","volume":"7","author":"Bross P.F.","year":"2001","unstructured":"Bross, P.F., Beitz, J., Chen, G., et al. Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia. Clin. Cancer Res. 2001, 7, 1490\u20131496.","journal-title":"Clin. Cancer Res"},{"key":"e_1_3_1_15_1","first-page":"235","article-title":"Gene therapy with immunotoxins","volume":"166","author":"Vallera D.A","year":"2001","unstructured":"Vallera, D.A. Gene therapy with immunotoxins. Methods Mol. Biol. 2001, 166, 235\u2013246.","journal-title":"Methods Mol. Biol"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0093-7754(03)00241-0"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.5858\/2008-132-424-AOITI"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.165.2.3498971"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e3282f401d6"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2008.10.006"},{"key":"e_1_3_1_21_1","first-page":"47","article-title":"Radionuclide imaging of infection","volume":"32","author":"Love C.","year":"2004","unstructured":"Love, C., Palestro, C.J. Radionuclide imaging of infection. J. Nucl. Med. Technol. 2004, 32, 47\u201357; quiz 58.","journal-title":"J. Nucl. Med. Technol"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-004-1614-x"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910215)67:4 <1253::AID-CNCR2820671523>3.0.CO;2-J"},{"key":"e_1_3_1_24_1","volume-title":"Immunology: Understanding the Immune System","author":"Elgert K.D","year":"2009","unstructured":"Elgert, K.D. Immunology: Understanding the Immune System. John Wiley and Sons, Inc., New Jersey, USA. 2009; Edition 2.","edition":"2"},{"key":"e_1_3_1_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00429-009-0230-8"},{"key":"e_1_3_1_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-005-0080-5"},{"key":"e_1_3_1_27_1","volume-title":"The Nucleic Acid Protocols Handbook","author":"Huang S.-H.","year":"2000","unstructured":"Huang, S.-H., Jong, A. Expression and preparation of fusion proteins from recombinant \u03bbgt11 phages. In Rapley, R., ed. The Nucleic Acid Protocols Handbook (pp. 367\u2013371). New Jersey: Humana Press Inc., 2000."},{"key":"e_1_3_1_28_1","doi-asserted-by":"publisher","DOI":"10.1124\/mi.3.6.310"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/dtb.2007.45755"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(96)00486-1"},{"key":"e_1_3_1_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(97)80009-7"},{"key":"e_1_3_1_32_1","doi-asserted-by":"publisher","DOI":"10.1593\/neo.08220"},{"key":"e_1_3_1_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706383"},{"key":"e_1_3_1_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09836-7"},{"key":"e_1_3_1_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21363"},{"key":"e_1_3_1_36_1","volume-title":"Foye\u2019s Principles of Medicinal Chemistry","author":"Reid R.F.","year":"2008","unstructured":"Reid, R.F., Sindelar, R.D. Pharmaceutical biotechnology\u2014from nucleic acids to personalized medicine. In Lemke, T.L., Williams, D.A., Roche, V.F., Zito, S.W., eds. Foye\u2019s Principles of Medicinal Chemistry (pp. 115\u2013174). Maryland and Pennsylvania: Lippincott Williams & Wilkins, 2008."},{"key":"e_1_3_1_37_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI28508"},{"key":"e_1_3_1_38_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543770903029201"},{"key":"e_1_3_1_39_1","first-page":"527","article-title":"Synagis: an anti-RSV monoclonal antibody","volume":"25","author":"Driver L.C.","year":"1999","unstructured":"Driver, L.C., Oertel, M.D. Synagis: an anti-RSV monoclonal antibody. Pediatr. Nurs. 1999, 25, 527\u2013530.","journal-title":"Pediatr. Nurs"},{"key":"e_1_3_1_40_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040178"},{"key":"e_1_3_1_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16506-9"},{"key":"e_1_3_1_42_1","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.3.1069-1074.2002"},{"key":"e_1_3_1_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200302140-00003"},{"key":"e_1_3_1_44_1","volume-title":"The Protein Protocols Handbook","author":"Bailey G.S","year":"2002","unstructured":"Bailey, G.S. Antibody techniques. In Walker, J.M., ed. The Protein Protocols Handbook (pp. 969\u2013970). New Jersey: Humana Press Inc., 2002."},{"key":"e_1_3_1_45_1","volume-title":"The Protein Protocols Handbook","author":"Bailey G.S","year":"2002","unstructured":"Bailey, G.S. Antibody techniques. In Walker, J.M., ed. The Protein Protocols Handbook (pp. 963\u2013966). New Jersey: Humana Press Inc., 2002."},{"key":"e_1_3_1_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-009-1263-1"},{"key":"e_1_3_1_47_1","volume-title":"Therapeutic Antibodies: Methods and Protocols","author":"Singh R.","year":"2009","unstructured":"Singh, R., Erickson, H.K. Therapeutic Antibodies: Methods and Protocols. New Jersey: Humana Press Inc., 2009."},{"key":"e_1_3_1_48_1","volume-title":"Chemistry of Protein Conjugation and Cross-Linking","author":"Wong S.S","year":"1991","unstructured":"Wong, S.S. Chemistry of Protein Conjugation and Cross-Linking. CRC Press LLC, Florida, USA. 1991."},{"key":"e_1_3_1_49_1","volume-title":"Drug Targeting: Strategies, Principles, and Applications (Methods in Molecular Medicine)","author":"Ghetie V.","year":"2000","unstructured":"Ghetie, V., Vitetta, E.S. Chemical construction of immunotoxins. In Francis, G.E., Delgado, C., eds. Drug Targeting: Strategies, Principles, and Applications (Methods in Molecular Medicine) (pp. 1\u201326). New Jersey: Humana press Inc., 2000."},{"key":"e_1_3_1_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e32832a6e4d"},{"key":"e_1_3_1_51_1","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1996.0718"},{"key":"e_1_3_1_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2006.09.061"},{"key":"e_1_3_1_53_1","unstructured":"BL22 immunotoxin. http:\/\/www.cancer.gov\/Templates\/drugdictionary.aspx?CdrID=43322 (accessed November 20 2009.)."},{"key":"e_1_3_1_54_1","unstructured":"National Cancer Institute. Clinical Trials. BL22 immunotoxin. http:\/\/www.cancer.gov\/search\/ResultsClinicalTrials.aspx? protocolsearchid=6445617 (accessed November 28 2009.)."},{"key":"e_1_3_1_55_1","doi-asserted-by":"publisher","DOI":"10.1208\/aapsj080363"},{"key":"e_1_3_1_56_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107263450402"},{"key":"e_1_3_1_57_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-5-601"},{"key":"e_1_3_1_58_1","doi-asserted-by":"publisher","DOI":"10.2147\/btt.s3084"},{"key":"e_1_3_1_59_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1983.tb01199.x"},{"key":"e_1_3_1_60_1","volume-title":"Flow Cytometry: Advanced Research and Clinical Applications","author":"Wood J.C.S.","year":"1989","unstructured":"Wood, J.C.S., Horton, A.F., Byrne, J.D., Pedroso, R.I., Bisnow, M., Auer, R.E. Dual laser excitation flow cytometry: the state of the art. In Yen, A., ed., Flow Cytometry: Advanced Research and Clinical Applications (pp. 5\u201362). Florida: CRC Press, Inc., 1989."},{"key":"e_1_3_1_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23219"},{"key":"e_1_3_1_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1529-1049(02)00054-5"},{"key":"e_1_3_1_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-1759(97)00209-3"},{"key":"e_1_3_1_64_1","volume-title":"Applications and Engineering of Monoclonal Antibodies","author":"King D.J","year":"1998","unstructured":"King, D.J. Monoclonal antibodies in research and diagnostic applications. In King, D.J., ed., Applications and Engineering of Monoclonal Antibodies (pp. 102\u2013109). London & Pennsylvania: Taylor & Francis Ltd., 1998."},{"key":"e_1_3_1_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-291X(83)80221-6"},{"key":"e_1_3_1_66_1","volume-title":"New Protein Techniques","author":"Kenney A.","year":"1988","unstructured":"Kenney, A., Goulding, L., Hill, C. The design, preparation, and use of immunopurification reagents. In Walker, J.M., ed. New Protein Techniques (pp. 99\u2013110). New Jersey: Humana Press, 1988."},{"key":"e_1_3_1_67_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.173.2.2678259"},{"key":"e_1_3_1_68_1","doi-asserted-by":"publisher","DOI":"10.1159\/000049789"},{"issue":"10","key":"e_1_3_1_69_1","first-page":"S19","article-title":"ProstaScint(R) scan: contemporary use in clinical practice","volume":"6","author":"Taneja S.S","year":"2004","unstructured":"Taneja, S.S. ProstaScint(R) scan: contemporary use in clinical practice. Rev. Urol. 2004, 6(Suppl 10), S19\u2013S28.","journal-title":"Rev. Urol"}],"container-title":["Immunopharmacology and Immunotoxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/08923971003646597","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:08:03Z","timestamp":1770894483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/08923971003646597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,3]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["10.3109\/08923971003646597"],"URL":"https:\/\/doi.org\/10.3109\/08923971003646597","relation":{},"ISSN":["0892-3973","1532-2513"],"issn-type":[{"value":"0892-3973","type":"print"},{"value":"1532-2513","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,3]]}}}